197 related articles for article (PubMed ID: 32343227)
1. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
Zhao S; Yudin Y; Rohacs T
Elife; 2020 Apr; 9():. PubMed ID: 32343227
[TBL] [Abstract][Full Text] [Related]
2. The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.
Zhao S; Rohacs T
Channels (Austin); 2021 Dec; 15(1):386-397. PubMed ID: 33853504
[TBL] [Abstract][Full Text] [Related]
3. Gain of channel function and modified gating properties in TRPM3 mutants causing intellectual disability and epilepsy.
Van Hoeymissen E; Held K; Nogueira Freitas AC; Janssens A; Voets T; Vriens J
Elife; 2020 May; 9():. PubMed ID: 32427099
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits.
Badheka D; Yudin Y; Borbiro I; Hartle CM; Yazici A; Mirshahi T; Rohacs T
Elife; 2017 Aug; 6():. PubMed ID: 28829742
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the voltage-sensing domain affect the alternative ion permeation pathway in the TRPM3 channel.
Held K; Gruss F; Aloi VD; Janssens A; Ulens C; Voets T; Vriens J
J Physiol; 2018 Jun; 596(12):2413-2432. PubMed ID: 29604058
[TBL] [Abstract][Full Text] [Related]
6. A Cataract-Causing Mutation in the TRPM3 Cation Channel Disrupts Calcium Dynamics in the Lens.
Zhou Y; Bennett TM; Ruzycki PA; Guo Z; Cao YQ; Shahidullah M; Delamere NA; Shiels A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334649
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function variants in the ion channel gene
Burglen L; Van Hoeymissen E; Qebibo L; Barth M; Belnap N; Boschann F; Depienne C; De Clercq K; Douglas AGL; Fitzgerald MP; Foulds N; Garel C; Helbig I; Held K; Horn D; Janssen A; Kaindl AM; Narayanan V; Prager C; Rupin-Mas M; Afenjar A; Zhao S; Ramaekers VT; Ruggiero SM; Thomas S; Valence S; Van Maldergem L; Rohacs T; Rodriguez D; Dyment D; Voets T; Vriens J
Elife; 2023 Jan; 12():. PubMed ID: 36648066
[TBL] [Abstract][Full Text] [Related]
8. Volatile anaesthetics inhibit the thermosensitive nociceptor ion channel transient receptor potential melastatin 3 (TRPM3).
Kelemen B; Lisztes E; Vladár A; Hanyicska M; Almássy J; Oláh A; Szöllősi AG; Pénzes Z; Posta J; Voets T; Bíró T; Tóth BI
Biochem Pharmacol; 2020 Apr; 174():113826. PubMed ID: 31987857
[TBL] [Abstract][Full Text] [Related]
9. Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release.
Held K; Kichko T; De Clercq K; Klaassen H; Van Bree R; Vanherck JC; Marchand A; Reeh PW; Chaltin P; Voets T; Vriens J
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1363-72. PubMed ID: 25733887
[TBL] [Abstract][Full Text] [Related]
10. Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
Krügel U; Straub I; Beckmann H; Schaefer M
Pain; 2017 May; 158(5):856-867. PubMed ID: 28106668
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
12. Activation and inhibition of transient receptor potential TRPM3-induced gene transcription.
Lesch A; Rubil S; Thiel G
Br J Pharmacol; 2014 May; 171(10):2645-58. PubMed ID: 24895737
[TBL] [Abstract][Full Text] [Related]
13. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [Abstract][Full Text] [Related]
14. Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3.
Straub I; Mohr F; Stab J; Konrad M; Philipp SE; Oberwinkler J; Schaefer M
Br J Pharmacol; 2013 Apr; 168(8):1835-50. PubMed ID: 23190005
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental disorders caused by variants in TRPM3.
Roelens R; Peigneur ANF; Voets T; Vriens J
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119709. PubMed ID: 38522727
[TBL] [Abstract][Full Text] [Related]
16. Activation of gene transcription via CIM0216, a synthetic ligand of transient receptor potential melastatin-3 (TRPM3) channels.
Rubil S; Thiel G
Channels (Austin); 2017 Jan; 11(1):79-83. PubMed ID: 27356187
[TBL] [Abstract][Full Text] [Related]
17. Computational and functional studies of the PI(4,5)P
Zhao S; Carnevale V; Gabrielle M; Gianti E; Rohacs T
J Biol Chem; 2022 Nov; 298(11):102547. PubMed ID: 36181791
[TBL] [Abstract][Full Text] [Related]
18. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
19. Partial Agonistic Actions of Sex Hormone Steroids on TRPM3 Function.
Persoons E; Kerselaers S; Voets T; Vriens J; Held K
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948452
[TBL] [Abstract][Full Text] [Related]
20. Promiscuous G-Protein-Coupled Receptor Inhibition of Transient Receptor Potential Melastatin 3 Ion Channels by Gβγ Subunits.
Alkhatib O; da Costa R; Gentry C; Quallo T; Bevan S; Andersson DA
J Neurosci; 2019 Oct; 39(40):7840-7852. PubMed ID: 31451581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
